Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Jianjin Pharmaceutical Co., Ltd. faces global regulatory markets such as China, the United States, and Europe. It is constructed and operated based on the current quality standards of the US FDA and China's NMPA and international high safety standards. It is the first batch of sterile injection enterprises in China that have passed the FDA certification as a whole, and is a national high-tech enterprise. We focus on the R&D a...
Jianjin Pharmaceutical Co., Ltd. faces global regulatory markets such as China, the United States, and Europe. It is constructed and operated based on the current quality standards of the US FDA and China's NMPA and international high safety standards. It is the first batch of sterile injection enterprises in China that have passed the FDA certification as a whole, and is a national high-tech enterprise. We focus on the R&D and commercialization of small-molecule chemical drugs, antibody drugs, new drug delivery systems, nucleic acid-based macromolecular biological drugs and new vaccines. Our independent research and development

List your booth number for exhibitions, ask us